SCHEMBL26659458

SCHEMBL26659458

C/C(=C\C(=O)O)C(=O)Nc1ccc(C(=O)O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 2/20 0.53
▸ PARP1 P09874 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ POLB P06746 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CXCR2 P25025 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26659388 1.00 KDM5A (0.53) KDM5APARP1KDM4EALDH1A1CYP1A2
SCHEMBL9621666 0.80 KDM5A (0.53) KDM5AKDM4EALDH1A1MAPTPOLB
3-Hydroxy-4-Acetylaminobenzoic Acid SCHEMBL31026207 0.79 MAPT (0.65) KDM5AKDM4EALDH1A1MAPTPOLB
3-Hydroxy-4-Acetylaminobenzoic Acid SCHEMBL8018270 0.79 MAPT (0.65) KDM5AKDM4EALDH1A1MAPTPOLB
SCHEMBL12850382 0.78 GAA (0.58) PARP1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL15412073 0.78 GAA (0.58) PARP1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL5177083 0.78 GAA (0.58) PARP1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL26659440 0.78 ALDH1A1 (0.51) PARP1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL26659421 0.78 ALDH1A1 (0.51) PARP1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL26659445 0.73 KDM4E (0.50) PARP1KDM4EALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KANEKA CORPORATION (JP) 2023-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KDM5C, DHX15, KDM5A KDM5A 3/4885PARP1 48/4885KDM4E 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback